CRISPR Therapeutics AG
Patents, Design & Utilities
Last updated:
List of all CRISPR Therapeutics AG patents 129 in total
| Status | Patent |
|---|---|
Grant | Utility: Universal donor cells Filling date: 12 Sep 2025 Issue date: 6 Sep 2022 |
Grant | Utility: Universal donor cells Filling date: 12 Sep 2025 Issue date: 6 Sep 2022 |
Application | Utility: ALLOGENEIC CELL THERAPY OF B CELL MALIGNANCIES USING GENETICALLY ENGINEERED T CELLS TARGETING CD19 Filling date: 12 Sep 2025 Issue date: 11 Aug 2022 |
Grant | Utility: Materials and methods for treatment of primary hyperoxaluria type 1 (PH1) and other alanine-glyoxylate aminotransferase (AGXT) gene related conditions or disorders Filling date: 12 Sep 2025 Issue date: 9 Aug 2022 |
Application | Utility: ANTI-CD33 IMMUNE CELL CANCER THERAPY Filling date: 12 Sep 2025 Issue date: 21 Jul 2022 |
Grant | Utility: Allogeneic cell therapy of B cell malignancies using genetically engineered T cells targeting CD19 Filling date: 12 Sep 2025 Issue date: 19 Jul 2022 |
Application | Utility: UNIVERSAL DONOR CELLS Filling date: 12 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR DIFFERENTIATING STEM CELLS INTO NK CELLS Filling date: 12 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: CO-USE OF LENALIDOMIDE WITH CAR-T CELLS Filling date: 12 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: GENE-EDITED NATURAL KILLER CELLS Filling date: 12 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: GENE-EDITED NATURAL KILLER CELLS Filling date: 12 Sep 2025 Issue date: 2 Jun 2022 |
Grant | Utility: Compositions and methods for genomic editing by insertion of donor polynucleotides Filling date: 12 Sep 2025 Issue date: 17 May 2022 |
Application | Utility: NOVEL HIGH FIDELITY RNA-PROGRAMMABLE ENDONUCLEASE SYSTEMS AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: ALLOGENEIC CELL THERAPY OF B CELL MALIGNANCIES USING GENETICALLY ENGINEERED T CELLS TARGETING CD19 Filling date: 12 Sep 2025 Issue date: 21 Apr 2022 |
Grant | Utility: Materials and methods for engineering cells and uses thereof in immuno-oncology Filling date: 12 Sep 2025 Issue date: 12 Apr 2022 |
Application | Utility: GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION HAVE IMPROVED FUNCTIONALITY AND PERSISTENCE Filling date: 12 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION HAVE IMPROVED FUNCTIONALITY AND PERSISTENCE Filling date: 12 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT CONE-ROD DYSTROPHY Filling date: 12 Sep 2025 Issue date: 17 Mar 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR GENE EDITING FOR HEMOPHILIA A Filling date: 12 Sep 2025 Issue date: 17 Mar 2022 |
Application | Utility: UNIVERSAL DONOR CELLS Filling date: 12 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: ANTI-IDIOTYPE ANTIBODIES TARGETING ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR Filling date: 12 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: GENE-EDITING COMPOSITIONS AND METHODS TO MODULATE FAAH FOR TREATMENT OF NEUROLOGICAL DISORDERS Filling date: 12 Sep 2025 Issue date: 24 Feb 2022 |
Grant | Utility: Methods and compositions for treating cancer Filling date: 12 Sep 2025 Issue date: 22 Feb 2022 |
Application | Utility: OPTIMIZED mRNA ENCODING CAS9 FOR USE IN LNPs Filling date: 12 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 1 (SCA1) AND OTHER SPINOCEREBELLAR ATAXIA TYPE 1 PROTEIN (ATXN1) GENE RELATED CONDITIONS OR DISORDERS Filling date: 12 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: ALLOGENEIC CELL THERAPY OF ACUTE LYMPHOBLASTIC LEUKEMIA USING GENETICALLY ENGINEERED T CELLS TARGETING CD19 Filling date: 12 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: UNIVERSAL DONOR CELLS Filling date: 12 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR NHEJ-MEDIATED GENOME EDITING Filling date: 12 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF USHER SYNDROME TYPE 2A Filling date: 12 Sep 2025 Issue date: 30 Dec 2021 |
Grant | Utility: Materials and methods for engineering cells and uses thereof in immuno-oncology Filling date: 12 Sep 2025 Issue date: 28 Dec 2021 |
Grant | Utility: Materials and methods for engineering cells and uses thereof in immuno-oncology Filling date: 12 Sep 2025 Issue date: 21 Dec 2021 |
Application | Utility: ANTI-CD70 ANTIBODIES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: UNIVERSAL DONOR CELLS Filling date: 12 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: GENETICALLY ENGINEERED CAR T CELLS THAT SECRET INTERLEUKIN-12 AND THERAPEUTIC USES THEREOF Filling date: 12 Sep 2025 Issue date: 25 Nov 2021 |
Grant | Utility: Universal donor cells Filling date: 12 Sep 2025 Issue date: 23 Nov 2021 |
Application | Utility: MESSENGER RNA ENCODING CAS9 FOR USE IN GENOME-EDITING SYSTEMS Filling date: 12 Sep 2025 Issue date: 18 Nov 2021 |
Grant | Utility: Materials and methods for treatment of Amyotrophic Lateral Sclerosis (ALS) and other related disorders Filling date: 12 Sep 2025 Issue date: 16 Nov 2021 |
Application | Utility: MASKED CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO TYROSINE-PROTEIN KINASE LIKE 7 (PTK7) AND IMMUNE CELLS EXPRESSING SUCH Filling date: 12 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: UNIVERSAL DONOR CELLS Filling date: 12 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR DELIVERING TRANSGENES Filling date: 12 Sep 2025 Issue date: 11 Nov 2021 |
Grant | Utility: Materials and methods for engineering cells and uses thereof in immuno-oncology Filling date: 12 Sep 2025 Issue date: 9 Nov 2021 |
Application | Utility: ANTI-LIV1 IMMUNE CELL CANCER THERAPY Filling date: 12 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: ANTI-PTK7 IMMUNE CELL CANCER THERAPY Filling date: 12 Sep 2025 Issue date: 23 Sep 2021 |
Grant | Utility: Universal donor cells Filling date: 12 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Universal donor cells Filling date: 12 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Universal donor cells Filling date: 12 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Universal donor cells Filling date: 12 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Materials and methods for treatment of Usher syndrome type 2A and/or non-syndromic autosomal recessive retinitis pigmentosa (ARRP) Filling date: 12 Sep 2025 Issue date: 14 Sep 2021 |
Application | Utility: ALLOGENEIC CELL THERAPY OF B CELL MALIGNANCIES USING GENETICALLY ENGINEERED T CELLS TARGETING CD19 Filling date: 12 Sep 2025 Issue date: 2 Sep 2021 |
Grant | Utility: Universal donor cells Filling date: 12 Sep 2025 Issue date: 31 Aug 2021 |
Showing 1 to 50 of 129 patents.